Skip to Content
Merck

71663

Sodium phosphate dibasic dodecahydrate

tested according to Ph. Eur.

Synonym(s):

Dinatrii phosphas dodecahydricus, sec-Sodium phosphate, Disodium hydrogen phosphate dodecahydrate, Disodium phosphate, di-Sodium hydrogen phosphate dodecahydrate

Slide 1 of 1
Sign In to View Organizational & Contract Pricing.

Select a Size

1 KG

₪586.00

₪586.00

Please contact Customer Service for Availability
Request a Bulk Order

About This Item

Linear Formula:
Na2HPO4 · 12H2O
CAS Number:
10039-32-4
Molecular Weight:
358.14
NACRES:
NA.25
PubChem Substance ID:
329763414
UNSPSC Code:
12161700
EC Number:
231-448-7
MDL number:
MFCD00149181

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Sodium phosphate dibasic dodecahydrate, tested according to Ph. Eur.

InChI key

DGLRDKLJZLEJCY-UHFFFAOYSA-L

InChI

1S/2Na.H3O4P.12H2O/c;;1-5(2,3)4;;;;;;;;;;;;/h;;(H3,1,2,3,4);12*1H2/q2*+1;;;;;;;;;;;;;/p-2

SMILES string

O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O

Quality Level

200

agency

tested according to Ph. Eur.

assay

98.5-102.5%

form

crystalline

solubility

water: ~35.8 g/L at 20 °C

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
04273716491.06573
Sodium phosphate dibasic dodecahydrate tested according to Ph. Eur.

Sigma-Aldrich

71663

Sodium phosphate dibasic dodecahydrate

Sodium phosphate dibasic dodecahydrate meets analytical specification of Ph. Eur., BP, E339, 98.5-102.5% (T)

Sigma-Aldrich

04273

Sodium phosphate dibasic dodecahydrate

Sodium phosphate dibasic dodecahydrate BioXtra, ≥99.0% (T)

Sigma-Aldrich

71649

Sodium phosphate dibasic dodecahydrate

di-Sodium hydrogen phosphate dodecahydrate crystalline, EMPROVE® EXPERT, Ph. Eur., BP, ChP, JP, USP

SAFC

1.06573

di-Sodium hydrogen phosphate dodecahydrate

assay

98.5-102.5%

assay

98.5-102.5% (T)

assay

≥99.0% (T)

assay

-

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

500

form

crystalline

form

crystals

form

crystals

form

crystalline, solid

solubility

water: ~35.8 g/L at 20 °C

solubility

-

solubility

H2O: 0.1 M at 20 °C, clear, colorless

solubility

218 g/L

agency

USP/NF, tested according to Ph. Eur.

agency

meets analytical specifications of BP, meets analytical specifications of Ph. Eur.

agency

-

agency

BP, ChP, JP, Ph. Eur., USP

Application


  • The gelation behavior of thiolated citrus high-methoxyl pectin induced by sodium phosphate dibasic dodecahydrate.: This research explores how sodium phosphate dibasic dodecahydrate influences the gelation properties of thiolated citrus pectin, showcasing potential applications in food science and pharmaceuticals for controlled gelation processes (Chen J et al., 2022).

  • Use of cellulose nanofibril (CNF)/silver nanoparticles (AgNPs) composite in salt hydrate phase change material for efficient thermal energy storage.: Demonstrates the utility of sodium phosphate dibasic dodecahydrate in enhancing the performance of phase change materials, which are critical for energy storage systems, indicating its role in improving thermal energy storage efficiency (Shen Z et al., 2021).

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCN1863
BCCM4949
BCCL9055
BCCL5416
BCCL0807

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Karen Sliwa et al.
Heart (British Cardiac Society), 100(24), 1967-1974 (2014-09-18)
Lack of evidence-based data on the spectrum of cardiovascular disease (CVD) in pregnancy or in the postpartum period, as well as on maternal and fetal outcome, provides challenges for treating physicians, particularly in areas of low resources. The objectives of
Yuichiro Yano et al.
Journal of the American College of Cardiology, 65(4), 327-335 (2015-01-31)
Isolated systolic hypertension (ISH), defined as systolic blood pressure (SBP) ≥140 mm Hg and diastolic blood pressure (DBP) <90 mm Hg, in younger and middle-aged adults is increasing in prevalence. The aim of this study was to assess the risk
Matthew H Crouthamel et al.
Arteriosclerosis, thrombosis, and vascular biology, 33(11), 2625-2632 (2013-08-24)
Elevated serum phosphate has emerged as a major risk factor for vascular calcification. The sodium-dependent phosphate cotransporter, PiT-1, was previously shown to be required for phosphate-induced osteogenic differentiation and calcification of cultured human vascular smooth muscle cells (VSMCs), but its
Matthew R Weir et al.
Journal of clinical hypertension (Greenwich, Conn.), 16(12), 875-882 (2014-10-21)
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure (BP) and osmotic diuresis- and intravascular volume reduction-related adverse events (AEs) were evaluated using pooled data from four placebo-controlled, phase 3 studies in patients with type 2
Luciano Candilio et al.
Heart (British Cardiac Society), 101(3), 185-192 (2014-09-26)
Remote ischaemic preconditioning (RIPC), using brief cycles of limb ischaemia/reperfusion, is a non-invasive, low-cost intervention that may reduce perioperative myocardial injury (PMI) in patients undergoing cardiac surgery. We investigated whether RIPC can also improve short-term clinical outcomes. One hundred and
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service